A glial circadian gene expression atlas reveals cell type and disease-specific reprogramming in response to amyloid pathology or aging.
Patrick W. Sheehan,Stuart B Fass,Darshan Sapkota,Sylvia Kang,Henry C. Hollis,Jennifer H. Lawrence,Ron C. Anafi,Joseph D. Dougherty,John D. Fryer,Erik S Musiek
DOI: https://doi.org/10.1101/2024.05.28.596297
2024-06-01
Abstract:While circadian rhythm disruption may promote neurodegenerative disease, how aging and neurodegenerative pathology impact circadian gene expression patterns in different brain cell types is unknown. Here, we used translating ribosome affinity purification methods to define the circadian translatomes of astrocytes, microglia, and bulk cerebral cortex, in healthy mouse brain and in the settings of amyloid-beta plaque pathology or aging. Our data reveal that glial circadian translatomes are highly cell type-specific and exhibit profound, context-dependent reprogramming of rhythmic transcripts in response to amyloid pathology or aging. Transcripts involved in glial activation, immunometabolism, and proteostasis, as well as nearly half of all Alzheimer Disease (AD)-associated risk genes, displayed circadian oscillations, many of which were altered by pathology. Amyloid-related differential gene expression was also dependent on time of day. Thus, circadian rhythms in gene expression are cell- and context dependent and provide important insights into glial gene regulation in health, AD, and aging.
Neuroscience